Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Retsas

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
History of Medicine|January 1, 1981
Medicine and the Olympic games of antiquityS Retsas
Melanoma Research|July 27, 2001
Prognostic factors in therapeutic lymphadenectomy in melanomaS Retsas
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapyS Retsas
Clinical and Experimental Dermatology|March 1, 1997
Systemic treatment of malignant melanoma: grade is as important as stageS Retsas
British Medical Journal (Clinical Research Ed.)|March 12, 1983
Sun beds and melanomaS Retsas
British Medical Journal|December 30, 1972
Insulin abuse by a drug addictS Retsas
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 17, 2007
Systemic treatment of melanoma: quo vadis oncologist?S Retsas
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
The treatment of melanoma at Westminster Hospital in the 20th centuryS Retsas
Critical Reviews in Oncology/Hematology|October 30, 2001
Adjuvant therapy of malignant melanoma: is there a choice?S Retsas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Adjuvant interferon alfa-2b for high-risk melanomaS Retsas
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
History of Medicine|January 1, 1981
Medicine and the Olympic games of antiquityS Retsas
Melanoma Research|July 27, 2001
Prognostic factors in therapeutic lymphadenectomy in melanomaS Retsas
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapyS Retsas
Clinical and Experimental Dermatology|March 1, 1997
Systemic treatment of malignant melanoma: grade is as important as stageS Retsas
British Medical Journal (Clinical Research Ed.)|March 12, 1983
Sun beds and melanomaS Retsas
British Medical Journal|December 30, 1972
Insulin abuse by a drug addictS Retsas
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 17, 2007
Systemic treatment of melanoma: quo vadis oncologist?S Retsas
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 3, 2013
The treatment of melanoma at Westminster Hospital in the 20th centuryS Retsas
Critical Reviews in Oncology/Hematology|October 30, 2001
Adjuvant therapy of malignant melanoma: is there a choice?S Retsas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Adjuvant interferon alfa-2b for high-risk melanomaS Retsas
Pageof 7